All Outputs (6)

Cryogenics free production of hyperpolarized 129Xe and 83Kr for biomedical MRI applications (2013)
Journal Article
Hughes-Riley, T., Six, J. S., Lilburn, D., Stupic, K. F., Dorkes, A. C., Shaw, D. E., …Meersmann, T. (2013). Cryogenics free production of hyperpolarized 129Xe and 83Kr for biomedical MRI applications. Journal of Magnetic Resonance, 237, https://doi.org/10.1016/j.jmr.2013.09.008

As an alternative to cryogenic gas handling, hyperpolarized (hp) gas mixtures were extracted directly from the spin exchange optical pumping (SEOP) process through expansion followed by compression to ambient pressure for biomedical MRI applications.... Read More about Cryogenics free production of hyperpolarized 129Xe and 83Kr for biomedical MRI applications.

Pulmonary MRI contrast using Surface Quadrupolar Relaxation (SQUARE) of hyperpolarized 83Kr (2013)
Journal Article
Six, J. S., Hughes-Riley, T., Lilburn, D. M., Dorkes, A. C., Stupic, K. F., Shaw, D. E., …Meersmann, T. (2014). Pulmonary MRI contrast using Surface Quadrupolar Relaxation (SQUARE) of hyperpolarized 83Kr. Magnetic Resonance Imaging, 32(1), 48-53. https://doi.org/10.1016/j.mri.2013.08.007

Hyperpolarized 83Kr has previously been demonstrated to enable MRI contrast that is sensitive to the chemical composition of the surface in a porous model system. Methodological advances have lead to a substantial increase in the 83Kr hyperpolarizati... Read More about Pulmonary MRI contrast using Surface Quadrupolar Relaxation (SQUARE) of hyperpolarized 83Kr.

Metrics of salbutamol use as predictors of future adverse outcomes in asthma (2013)
Journal Article
Patel, M., Pilcher, J., Reddel, H. K., Pritchard, A., Corin, A., Helm, C., …Beasley, R. (2013). Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Clinical and Experimental Allergy, 43(10), https://doi.org/10.1111/cea.12166

Background Beta-agonist overuse is associated with adverse outcomes in asthma, however, the relationships between different metrics of salbutamol use and future risk are uncertain. Objective To investigate the relationship between metrics of s... Read More about Metrics of salbutamol use as predictors of future adverse outcomes in asthma.

What drives the 'August effect'?: an observational study of the effect of junior doctor changeover on out of hours work (2013)
Journal Article
Blakey, J., Fearn, A., & Shaw, D. E. (2013). What drives the 'August effect'?: an observational study of the effect of junior doctor changeover on out of hours work. JRSM Short Reports, 4(8), https://doi.org/10.1177/2042533313489823

Objective: To investigate whether measurements of junior doctor on-call workload and performance can clarify the mechanisms underlying the increase in morbidity and mortality seen after junior doctor changeover: the ‘August effect’. Design: Quanti... Read More about What drives the 'August effect'?: an observational study of the effect of junior doctor changeover on out of hours work.

Short-acting ?-agonist use as a marker of current asthma control (2013)
Journal Article
Patel, M., Pilcher, J., Munro, C., Hosking, A., Pritchard, A., Shaw, D., …Beasley, R. (in press). Short-acting β-agonist use as a marker of current asthma control. Journal of Allergy and Clinical Immunology: In Practice, 1(4), https://doi.org/10.1016/j.jaip.2013.04.008

Background The relationship between current asthma symptoms and rescue bronchodilator (reliever) use is uncertain, leading to different recommendations about the preferred reliever metric to use when assessing asthma control. In a 6-month randomiz... Read More about Short-acting ?-agonist use as a marker of current asthma control.

Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial (2013)
Journal Article
Patel, M., Pilcher, J., Pritchard, A., Perrin, K., Travers, J., Shaw, D., …Beasley, R. (2013). Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Respiratory Medicine, 1(1), 32-42. https://doi.org/10.1016/S2213-2600%2813%2970007-9

Background The Single combination budesonide–formoterol inhaler Maintenance And Reliever Therapy (SMART) regimen reduces severe asthma exacerbations in patients, but whether the high doses of corticosteroid and β agonist increase the risk of adverse... Read More about Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.